Iron chelators for thalassaemia.
Hershko
C
C
Department of Medicine, Shaare Zedek Medical Centre, Jerusalem, Israel.
Konijn
A M
AM
Link
G
G
D000284:Administration, Oral; D001372:Aza Compounds / Q000627:therapeutic use; D002614:Chelating Agents / Q000627:therapeutic use*; D000077543:Deferiprone; D003676:Deferoxamine / Q000627:therapeutic use*; D004492:Edetic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007501:Iron / Q000378:metabolism; D007502:Iron Chelating Agents / Q000627:therapeutic use; D019190:Iron Overload / Q000188:drug therapy / Q000209:etiology; D008134:Long-Term Care; D011728:Pyridones / Q000627:therapeutic use; D013789:Thalassemia / Q000188:drug therapy* / Q000378:metabolism
D001372:Aza Compounds; D002614:Chelating Agents; D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone; C037740:N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid; D004492:Edetic Acid; D007501:Iron; D003676:Deferoxamine